Comparison of 3 algorithms for basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery

Endocrine Practice

Volumn 17, Issue 5, 2011, Pages 753-758

  Dungan, Kathleen ^a   Hall, Christine ^a   Schuster, Dara ^a   Osei, Kwame ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN DETEMIR;

ADULT; AGED; ALGORITHM; ARTICLE; CARBOHYDRATE INTAKE; DIABETES MELLITUS; DRUG ADMINISTRATION ROUTE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART SURGERY; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTRAVENOUS ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; THORAX SURGERY; TREATMENT OUTCOME;

EID: 80054840699     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11027.OR     Document Type: Article

References (65)

1. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: Institute of Medicine of the National Academies; 2011. http://www.iom.edu/Reports/2010/ Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx. Accessed August 29, 2011.
2. Chung M, Balk EM, Brendel M, et al; Tufts Evidence-Based Practice Center. Vitamin D and Calcium: A Systematic Review of Health Outcomes. Evidence Report/Technology Assessment. Number 183. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
3. Wang TJ, Pencina MJ, Booth Dl, et al. Vitamin D defi-ciency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
4. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008;168: 1174-1180.
5. Wang L, Manson JE, Sing Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in preven-tion of cardiovascular events. Ann Intern Med. 2010;152: 315-323.
6. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supple-mentation: Randomised controlled trial. BMJ. 2008;336: 262-266.
7. Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: Results of a 5-year, double-blind, placebo-con-trolled trial in elderly women. Arch Intern Med. 2006;166: 869-875.
8. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardio-vascular events: Meta-analysis. BMJ. 2010;341:c3691.
9. Lewis JR, Calver J, Zhu K, Flicker L, Prince RL. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: Results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res. 2011;26:35-41.
10. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med. 2006; 119:777-85.
11. Shapses SA, Manson JE. Vitamin D and prevention of cardiovascular disease and diabetes: Why the evidence falls short. JAMA. 2011;305:2565-2567.
12. Holick MF. Vitamin D requirements for humans of all ages: New increased requirements for women and men 50 years and older. Osteoporos Int. 1998;8(Suppl 2):S24-S29.
13. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357: 266-281.
14. Rosen C. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364:248-254.
15. Binkley N, Nonotny R, Krueger D, et al. Low vita-min D status despite abundant sunlight exposure. J Clin Endocrinol Metab. 2007;92:2130-2135.
16. Binkley N, Krueger D, Lensmeyer G. 25-Hydroxyvitamin D measurement 2009: A review for clinicians. J Clin Densitom. 2009;12:417-427.
17. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011;86:50-60.
18. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D sta-tus of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88:1519-1527.
19. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D sta-tus. Osteoporos Int. 2005;16:713-716.
20. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(Suppl 6):1689S-1696S.
21. Heaney RP, Horst RL, Cullen DM, Armas LA. Vitamin D3 distribution and status in the body. J Am Coll Nutr. 2009;28:252-256.
22. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-hydroxylation of vitamin D3: Relation of circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87:1738-1742.
23. Manson JE, Mayne ST, Clinton SK. Vitamin D and pre-vention of cancer-ready for prime time? N Engl J Med. 2011;364:1385-1387.
24. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board, Institute of Medicine. DRI Dietary Reference Intakes for Calcium Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: The National Academies Press, 1997.
25. Watts NB, Bilezikian JP, Camacho PM, et al; AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010;16(Suppl 3):1-37.
26. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin d defi-ciency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
27. Manson JE, Buring JE. Vitamin D and Omega-3 Trial (VITAL). In: ClinicalTrials.gov (Internet). Bethesda, MD: National Library of Medicine (US). 2010. Cited Dec 21. Available at: Http://clinicaltrials.gov/show/NCT01169259. NLM Identifier: NCT01169259.
28. Manson JE. Vitamin D and the heart: Why we need large-scale clinical trials. Cleve Clin J Med. 2011;77:903-910.
29. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Int Med. 2007;167:1730-1737.
30. Chung M, Balk EM, Brendel M, et al. Vitamin D and calcium: A systematic review of health outcomes. Evid Rep Technol Assess (Full Rep). 2009:1-420.
31. LaCroix AZ, Kotchen J, Anderson G, et al. Calcium plus vitamin D supplementation and mortality in postmeno-pausal women: The Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009;64:559-567.
32. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-1637.
33. Heaney RP. 25-Hydroxyvitamin D and calcium absorp-tion. Am J Clin Nutr. 2011;93:220-221.
34. Heaney RP, Vieth R, Hollis BW. Vitamin D efficacy and safety. Arch Intern Med. 2011;171:266.
35. Gal-Moscovici A, Sprague SM. Use of vitamin D in chronic kidney disease patients. Kidney Int. 2010;78:146-151.
36. Khosla N, Sprague SM. When is vitamin D contraindi-cated in dialysis patients? Semin Dial. 2009;22:249-251.
37. Andress DL. Adynamic bone in patients with chronic kid-ney disease. Kidney Int. 2008;73:1345-1354.
38. Andress DL. Vitamin D treatment in chronic kidney dis-ease. Semin Dial. 2005;18:315-321.
39. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007;22(Suppl 2):V64-V68.
40. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assess-ment for vitamin D. Am J Clin Nutr. 2007;85:6-18.
41. Binkley N, Gemar D, Engelke J, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab. 2011;96:981-988.
42. Heaney RP. Calcium supplementation and incident kidney stone risk: A systematic review. J Am Coll Nutr. 2008;27: 519-527.
43. Liebman SE, Taylor JG, Bushinsky DA. Idiopathic hypercalciuria. Curr Rheumatol Rep. 2008;8:70-75.
44. Bushinsky DA. Recurrent hypercalciuric nephrolithiasis: Does diet help? N Engl J Med. 2002;346:124-125.
45. Lund RJ, Andress DL, Amdahl M, Williams LA, Heaney RP. Differential effects of paracalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients. Am J Nephrol. 2010;3:165-170.
46. Sprague SM, Coyne D. Control of secondary hyperpara-thyroidism by vitamin D receptor agonists in chronic kid-ney disease. Clin J Am Soc Nephrol. 2010;5:512-518.
47. Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease? A system-atic review. Semin Arthritis Rheum. 2011;40:512-531.
48. Scragg R. Vitamin D and public health: An overview of recent research on common diseases and mortality in adult-hood. Public Health Nutr. 2011;14:1515-1532.
49. Rubin MR, Bilezikian JP. Hypoparathyroidism: Clini-cal features, skeletal microstructure, and parathyroid hor-mone replacement. Arq Bras Endocrinol Metab. 2010;54: 220-226.
50. Block GA. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: Focus on mortality. Curr Opin Nephrol-Hypertens. 2011;20:376-381.
51. Moe SM, Block GA, Langman CB. Oral phosphate bind-ers in patients with kidney failure. N Engl J Med. 2010; 363:990.
52. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guide-line for the diagnosis, evaluation, prevention, and treat-ment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009:S1-S130.
53. Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-anal-ysis. JAMA. 2011;16;305:1119-1127.
54. Langman CB, Cannata-Andía, JB. Calcium and chronic kidney disease: Myths and realities. Introduction. Clin J Am Soc Nephrol. 2010;5(Suppl 1):S1-S2.
55. West SL, Swan VJ, Jamal SA. Effects of calcium on cardiovascular events in patients with chronic kidney dis-ease and in a healthy population. Clin J Am Soc Nephrol. 2010;5(Suppl 1):S41-S47.
56. Leifsson BJ, Ahrén B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab. 1996;81:2149-2153.
57. Fitzpatrick L, Bilezikian JP, Silverberg SL. Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep. 2008;6:77-83.
58. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among post-menopausal women. Am J Epidemiol. 1999;149:151-161.
59. Van der Vijver LP, van der Waal MA, Weterings KG, Dekker JM, Schouten EG, Kok FJ. Calcium intake and 28-year cardiovascular and coronary heart disease mortal-ity in Dutch civil servants. Int J Epidemiol. 1992;21:36-39.
60. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
61. Reid IR, Avenell A. Evidence-based policy on dietary cal-cium and vitamin D. J Bone Miner Res. 2011;26:452-454.
62. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects of meta-analysis. BMJ. 2011;342:d549.
63. Nordin BE, Lewis JR, Daly RM, et al. The calcium scare-what would Austin Bradford Hill have thought? Osteoporosis Int. 2011 [Epub ahead of print]
64. Prince RL, Zhu K, Lewis JR. Evidence of harm is uncon-vincing. BMJ. 2011;342:d3541.
65. Bolland MJ, Grey A, Reid IR. Authors' response to edito-rial. BMJ. 2011;342:d3520.